A naukri.com initiative
Appsilon
1M
273
Image Credit: Appsilon
Open-Source Adoption in Pharma: Opportunities and Challenges
- Open-source tools are gaining traction in the pharmaceutical industry with companies like Roche, Novo Nordisk, GSK, and Pfizer contributing to open-source repositories.
- Pharma is moving towards open-source tools like R due to benefits such as customization, integration capabilities, collaboration, rapid statistical advancements, and cost reduction.
- Challenges in adopting open-source tools in pharma include regulatory compliance, security, long-term maintenance, system integration, skill gaps, and change management.
- Key considerations for pharma leaders adopting open-source include building skills, fostering a supportive culture, and strategic planning.
- Roche's successful use of open-source tools in clinical trial data management and analytics, with tools like {admiral}, {teal}, and {rtables}, exemplifies effective integration.
- Pharmaceutical companies should focus on talent development, measuring ROI, strategic implementation, and active engagement in the open-source ecosystem when adopting open-source solutions.
- By strategically incorporating open-source tools, pharma companies can enhance efficiency, reproducibility, and cost savings in areas like data analysis and regulatory submissions.
- Successful open-source adoption in pharma requires a well-planned strategy aligning with both short-term goals and long-term vision for sustained benefits.
- Open-source adoption presents immediate benefits and long-term value in pharma, emphasizing the importance of a structured approach for success.
- The article was originally published on appsilon.com/blog, exploring the opportunities and challenges of open-source adoption in the pharmaceutical industry.
Read Full Article
16 Likes
For uninterrupted reading, download the app